[1] Marx N.Coronary heart disease[J]. Dtsch Med Wochenschr,2021,146(16):1021. [2] Katta N,Loethen T,Lavie CJ,et al.Obesity and coronary heart disease:Epidemiology,pathology,and coronary artery imaging[J]. Curr Probl Cardiol,2021,46(3):100655. [3] Alpert JS.New coronary heart disease risk factors[J]. Am J Med,2023,136(4):331-332. [4] 中国心血管健康与疾病报告2020[J]. 心肺血管病杂志,2021,40(9):885-889. [5] Cybulska B,Kłosiewicz-latoszek L. Landmark studies in coronary heart disease epidemiology. The Framingham Heart Study after 70 years and the Seven Countries Study after 60 years[J]. Kardiol Pol,2019,77(2):173-180. [6] Almarzooq ZI.The cost of coronary heart disease and the promise of prevention[J]. Eur J Prev Cardiol,2022,29(6):e213-e215. [7] 赵青,贾瑞秀. 治疗性健康生活方式用于冠心病二级预防的作用[J]. 中国基层医药,2022,29(1):126-128. [8] 刘小伟,王江挺,林森娜,等. 老年冠心病患者二级预防药物现况调查研究:指南与实践[J]. 浙江医学,2019,41(22):2402-2407. [9] 医格.冠心病一、二级预防ABC方案指南更新(下)[J]. 临床误诊误治,2018,31(6):2,117. [10] Arnett DK,Blumenthal RS,Albert MA,et al.2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. Circulation,2019,140(11):e596-e646. [11] 陈强,曲珊珊,黄欣. 中文版MMAS-8评价心血管慢病患者用药依从性的信效度分析与实践[J]. 中国药房,2019,30(2):268-271. [12] Bai MF,Wang X.Risk factors associated with coronary heart disease in women:A systematic review[J]. Herz,2020,45(Suppl 1):52-57. [13] Pagliaro BR,Cannata F,Stefanini GG,et al.Myocardial ischemia and coronary disease in heart failure[J]. Heart Fail Rev,2020,25(1):53-65. [14] Du J,Li Y,Zhao W.Autophagy and myocardial ischemia[J]. Adv Exp Med Biol,2020,1207:217-222. [15] Shao C,Wang J,Tian J,et al.Coronary artery disease:From mechanism to clinical practice[J]. Adv Exp Med Biol,2020,1177:1-36. [16] Delgado-lista J,Alcala-diaz JF,Torres-peña JD,et al. Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV):A randomised controlled trial[J]. Lancet,2022,399(10338):1876-1885. [17] Shen Q,He P,Wen M,et al.Secondary prevention of coronary heart disease:The effect of a nursing intervention using Cox's interaction model of client health behaviour[J]. J Adv Nurs,2021,77(10):4104-4119. [18] 赵桂琴,狄文娟,郭振峰. 冠心病规范化二级预防的临床结果分析[J]. 医学综述,2018,24(21):4350-4354. [19] 田艳红,黄小俊. 小剂量螺瑞酮联合阿司匹林在妊高症合并冠心病患者的临床治疗作用[J]. 中南医学科学杂志,2018,46(6):600-602. [20] 黄惠萍,王如兴,羊镇宇. 后他汀时代动脉粥样硬化性心血管疾病患者降脂治疗的研究进展[J]. 江苏大学学报(医学版),2020,30(4):364-368. [21] 汪玉君,宋巧凤,王希柱,等. 依折麦布联合他汀类药物对冠心病患者的调脂及抗炎作用[J]. 宁夏医科大学学报,2015,37(10):1227-1229. [22] 冯楠,张怡,段学锋,等. 冠心病患者二级预防用药情况及依从性调查[J]. 华南预防医学,2023,49(3):297-300. [23] 韩立霞. 冠心病患者的二级预防用药依从性分析及其相关影响因素[J]. 中国卫生产业,2016,13(10):175-177. |